utilizing modified CAR-T cells to increase the effectiveness of cancer immunotherapy.

Published Date: 08 Nov 2023

For many patients with cancers of the blood, bone marrow, or lymph glands, CAR-T cell therapy represents their last resort after more conventional therapies like chemotherapy have failed. A constraint on this therapy, which is safe and effective otherwise.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

2.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

3.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

CDC Alerts on Dramatic Rise in Human Parvovirus B19


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot